Related Experiment Video
Updated: Mar 29, 2026
14:49
Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira
Published on: August 14, 2021
5.8K
Cytokines in human leptospirosis.
Anna Papa1, Tzimoula Kotrotsiou2
1Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece annap@med.auth.gr.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|December 3, 2015
Summary
This study measured 27 cytokines in leptospirosis patients, finding elevated levels of IP-10, IL-6, and MCP-1. These cytokine profiles offer potential targets for immunotherapies in severe leptospirosis cases.
Area of Science:
- Immunology
- Infectious Diseases
- Pathogenesis
Background:
- Leptospirosis is a zoonotic disease of significant public health concern.
- Cytokines are implicated in the pathogenesis of leptospirosis.
- Understanding the host immune response is crucial for managing the disease.
Purpose of the Study:
- To measure and evaluate the levels of 27 cytokines in patients with acute leptospirosis.
- To differentiate cytokine profiles between mild and severe cases.
- To identify potential immunotherapeutic targets.
Main Methods:
- Measurement of 27 cytokines in 42 acute leptospirosis cases (47 samples from severe cases).
- Statistical analysis using SPSS.
- Comparison of cytokine levels between severe, mild, and control groups.
Main Results:
- Significant differences in IL-6, IL-8, GM-CSF, IP-10, MCP-1, and VEGF levels between severe cases and controls.
- Elevated IL-6, IP-10, and MCP-1 in most patients.
- Higher IP-10 levels in severe cases suggest a cellular immune response.
- Distinct cytokine peak times post-onset of illness.
- Lower TNF-α in severe cases with pulmonary involvement.
Conclusions:
- Cytokine profiles provide insights into the host immune response in leptospirosis.
- Identifying specific cytokines like IP-10 can aid in distinguishing disease severity.
- This knowledge can inform the development of immunotherapeutic strategies for severe leptospirosis, complementing antibiotic treatment.
